A carregar...
Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia
BACKGROUND: Approximately one-third of people with schizophrenia are treatment-resistant and some do not achieve remission with clozapine, the gold-standard antipsychotic medication for treatment-resistant schizophrenia. This study compared global and regional brain volumes between treatment-respond...
Na minha lista:
| Publicado no: | Int J Neuropsychopharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4540109/ https://ncbi.nlm.nih.gov/pubmed/25716781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|